M. Tea

Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria

C. Singer, D. Gschwantler-Kaulich, S. Narod, 2014, Clinical genetics.

Hereditary Breast and Ovarian Cancer: Structures of Care in Austria

E. Kubista, T. Wagner, D. Muhr, 2006, Breast Care.

Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.

J. Attems, E. Kubista, C. Singer, 2007, Endocrine-related cancer.

Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter.

J. Huber, J. Ott, M. Hermann, 2011, Thyroid : official journal of the American Thyroid Association.

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

R. Greil, M. Gnant, P. Regitnig, 2018 .

Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers

P. Oefner, F. Frommlet, E. Kubista, 2005, Human mutation.

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

R. Greil, Z. Bago-Horvath, P. Dubsky, 2017 .